What is a peptide's 'half-life' and what does it tell you?
Updated: 2026-09-09 · Basics
Short answer
Half-life is the time it takes for the blood concentration to fall by half. It is a descriptive measure of how the body clears a molecule, and it varies enormously between peptides — from minutes to days. It is useful for reading research, not a rule that by itself determines how anything should be used.
In plain English
- It is measured in pharmacokinetic studies using repeated blood samples.
- Chemical modifications such as albumin binding greatly extend how long some peptides persist.
- A short half-life does not mean 'no effect': some effects outlast the molecule.
- Dosing intervals for an approved medicine come from its label and a clinician, not from half-life alone.
What we know
- Pharmacokinetics for approved medicines are published in their regulatory labels.
- Half-life differs widely between native peptides and modified analogues.
What we don't know yet
- Many research peptides have no published human pharmacokinetic data.
- Animal data do not transfer directly to humans.
No schedules, intervals or doses are given here. Any decision about use belongs to a healthcare professional.